Secondaries announced 01.21.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Agile Therapeutics
Symbol: AGRX
Price: Last trade $7.06
Trade Date: 1/22
Shares: 4.25 million
Underwriter(s) William Blair, RBC Capital Markets
Co Manager(s) Janney Montgomery Scott, Cantor Fitzgerald & Co., FBR
Rating=Subscription Needed

Company: Synergy Resources
Symbol: SYRG
Price: Last trade $6.29
Trade Date: 1/22
Shares: 10 million
Underwriter(s) Credit Suisse
Rating=Subscription Needed

Company: Signature Bank
Symbol: SBNY
Price: Last trade $139.09
Trade Date: 1/22
Shares: 2.2 million
Underwriter(s) J.P. Morgan, Goldman Sachs
Rating=Subscription Needed